Reverse Transcriptase News and Research

RSS
ARIAD Pharmaceuticals commences ponatinib Phase 3 trial in newly diagnosed CML

ARIAD Pharmaceuticals commences ponatinib Phase 3 trial in newly diagnosed CML

Merck signs two licensing agreements for investigational HIV drug candidates

Merck signs two licensing agreements for investigational HIV drug candidates

Merck, Chimerix sign license agreement for CMX157 to treat HIV infection

Merck, Chimerix sign license agreement for CMX157 to treat HIV infection

HIV drug resistance rates rising in some parts of Africa

HIV drug resistance rates rising in some parts of Africa

All adult patients with HIV should be offered ART: International Antiviral Society-USA panel

All adult patients with HIV should be offered ART: International Antiviral Society-USA panel

HIV therapy affects bone mass within 2 years

HIV therapy affects bone mass within 2 years

Biochemists map structure of key protein-RNA complex required for assembly of telomerase

Biochemists map structure of key protein-RNA complex required for assembly of telomerase

Breckenridge finalizes agreement with Huahai to market Nevirapine Tablets

Breckenridge finalizes agreement with Huahai to market Nevirapine Tablets

New light on many biological differences between individual breast cancers

New light on many biological differences between individual breast cancers

No added HIV risk with hormonal contraceptives

No added HIV risk with hormonal contraceptives

ViiV, Shionogi announce initial results from dolutegravir Phase III study on HIV-1

ViiV, Shionogi announce initial results from dolutegravir Phase III study on HIV-1

Study identifies new hypervariable regions in human gut viruses

Study identifies new hypervariable regions in human gut viruses

Rapid influenza diagnostic tests highly accurate in children than in adults

Rapid influenza diagnostic tests highly accurate in children than in adults

Study reveals potential strength of different anti-HIV combination drugs

Study reveals potential strength of different anti-HIV combination drugs

Researchers discover function and expression of CD97 in malignant gliomas

Researchers discover function and expression of CD97 in malignant gliomas

ACTF, Merck announce new HIV initiatives

ACTF, Merck announce new HIV initiatives

First clinical trial of dapivirine-maraviroc ring to treat HIV in women

First clinical trial of dapivirine-maraviroc ring to treat HIV in women

First-ever phase 1 clinical trial of rectal HIV-prevention drug

First-ever phase 1 clinical trial of rectal HIV-prevention drug

Merck announces results from ISENTRESS Phase III combination study on HIV-1

Merck announces results from ISENTRESS Phase III combination study on HIV-1

Gilead announces EMA CHMP positive opinion for HIV-1 drug, Eviplera

Gilead announces EMA CHMP positive opinion for HIV-1 drug, Eviplera